eve Conference Variant Block
- Seth J. Goldenberg, Ph.D.
- Company: Asia Pacific Bio Intelligence LLC (APBI)
- Title:
- Topic: Internationalization of Chinese Pharmaceutical-Significance of publishing in western journals& the increased requirements of cGMP that will come with increased exports
- Introduction:
- President and Co-founder of Asia Pacific Bio Intelligence LLC (APBI). Dr. Goldenberg, a former Regulatory Chemist with the FDA, and current President of APBI holds a Ph.D. in Pharmacology from the University of Washington and a M.S. from the School of Biomedical Engineering at Drexel University. He has a strong record in drug development, FDA, business development, product licensing, grant writing, scientific patents, medical communications, and collaborations with academia and industry. Dr. Goldenberg has a strong publication record (Cell, Science, Nat Cell Biol) and understands not only what it takes to carry out scientific study, but also the importance of communicating it with the global scientific community to foster partnerships and collaboration. nike news
- Andrew Hua Jiang
- Company: Aleon Pharma International, LLC
- Title:
- Topic: 505(b)(2): A Fast Drug Development and Approval Pathway in the US The Development and FDA Review of TCM
- Introduction:
- Andrew Hua Jiang is currently the president of Aleon Pharma International, LLC, an international consulting firm providing strategic regulatory and development solutions to the Pharma & biotech industries. Prior to starting Aleon, Andrew had held various management positions in global regulatory affairs at several global pharmaceutical companies including Bayer HealthCare, Novartis, Astellas, Wyeth Consumer, etc. He has more than 12 years of experience in global regulatory affairs with focus on developing regulatory strategies and liaising with major health authorities including FDA, SFDA, EMA, Health Canada, etc. He led global regulatory project teams in the clinical development and regulatory submissions of pharmaceutical and biological products in multiple therapeutic areas including oncology, cardiovascular & metabolic diseases, urology, neurology, respiratory, etc. He has authored/prepared multiple IND and NDA submissions, and has held multiple formal meetings with tBasketball Shoes
- Dr. Jianxin Wang
- Company: School of pharmacy, Fudan University
- Title:
- Topic: R&D of New Dosage Forms of Traditional Chinese Medicine
- Introduction:
- Dr. Jianxin Wang is the head of the department of pharmaceutics, school of pharmacy, Fudan University. He obtained his Ph.D. in pharmaceutics from West China University of Medical Sciences in 1999. He has been a visiting scholar sponsored by CSC in the College of Pharmacy, University of Michigan form 2009 to 2010.The central theme of his research is drug delivery across biological barriers, in particular those of the GI tract and the blood-brain barrier. Dr. Wang is the principle investigator of 16 projects funded by the government. He has published about 60 papers co-edited 9 books, and holds 6 issued Chinese patents with 6 patent application pending. He is in the editorial board of Journal of International Pharmaceutical Research, Chinese Patent Medicine and Chinese Journal of Hospital Pharmacy. Dr. Wang has been awarded as “Shanghai labor model”, “Shanghai Youth Model”, “Shijiazhuang Pharmaceutical Group Award for Young Scientist in Pharmaceutics,Nike Sneakers
- Conglin Zuo
- Company: CEO and Facility Manager of JOINN Laboratories
- Title:
- Topic: Safety Assessment of Biopharmaceuticals
- Introduction:
- Expert of preclinical safety evaluation for drugs in China, CEO and Facility Manager of JOINN Laboratories. He has been engaged in medical scientific research work for a long time. He has solid medical theory bases and strong ability in scientific research. Being engaged in toxicological studies for more than 10 years and getting support from the older generation toxicologist, as a Study Director, he was responsible for more than 30 new drugs, 100 researches on specific studies; project includes single dose toxicity, repeated dose toxicity and topical toxicity test. He presented more than 10 papers in both domestic and international magazines and conferences. As the Facility Manager in 2002, all employees in the company were carrying out for a full range of GLP construction by his guidance. By doing so, Beijing JOINN Laboratories has successfully passed GLP inspection which organized by SFDA in April 2005 and passed the AAALAC accreditation in the year 2008 as well. He has made aKids Clothes
- Dr. Pingping JIANG
- Company: School of Chemical and Material Engineering, Jiangnan University
- Title:
- Topic: Application of new environmental plasticizer in pharmaceutical excipients
- Introduction:
- PhD Supervisor ， Professor of School of Chemical and Material Engineering, Jiangnan University, Wuxi， China Ministry of education and the China light industry federation scientific and technological achievements assessors, editorial board member of Plastics additives, chief editor of Plasticizer, Technical committee director of China plasticizer industry, committee member of China water-soluble polymer professional committee, expert of China engineering plastic committee additives expert group. Air Jordan V High Supreme
- Dr. Guopin ZHAO
- Company: Medical School of Jinan University
- Title:
- Topic: Combination of TCM and Western medicine and R&D of TCM dosage innovation
- Introduction:
- Title of Honour : ----Advanced individual as returned overseas students in Nanjing; ----"333 Project" academic, technical leader, Middle-aged experts with outstanding contributions, in Jiangsu Province; ----"Blue project" key teacher ; ----The Third-grade State Scientific and Technological Progress Prize; ----The first prize of Chinese medicine fundamental research of State ----Administration of Traditional Chinese Medicine; Research orientation: -----Clinical study of Digestive disease and cerebrovascular disease with integrative medicine; -----Ancient prescription of the treatment of intractable disease. ADIDAS ORIGINALS
- Dr. Xue KE
- Company: China Pharmaceutical University (CPU)
- Title:
- Topic:
- Introduction:
- Dr. X. KE, associate professor in China Pharmaceutical University (CPU). She obtained her B.S., M.S. and Ph.D. degree with a major of Pharmaceutics from CPU in China in 1994, 1997 and 2003, respectively. And at 2001, she got advanced studies at College of Pharmacy, Otago University in New Zealand. Then, she completed her Post-Doctoral Research Fellowship at School of life sciences, Nanjing University in China at 2010. Starting from Aug. 1997, she was engaged in teaching and research work in Department of Pharmaceutics in CPU. The research fields were mainly involved in studies of new pharmaceutical preparations, new dosage forms of drugs, and new drug delivery systems. She is serving as the principal investigator for several research projects including the one from National Natural Science Foundation of China (NSFC) and the two from Social Development Fund of Jiangsu Province. Also, she co-managed the awards from State Technical Platform for Drug Development, NSFC, National High Air Jordan XIV Low
- Qineng PING
- Company: China Pharmaceutical University (CPU)
- Title:
- Topic: R&D of new dosage form of pharmaceutical formulations
- Introduction:
- Ping Qineng，Professor of China Pharmaceutical University (CPU)，the Dean Emeritus of College of Pharmacy, the former Vice President of Pharmaceutics committee of Chinese Pharmaceutical Association and President of Pharmaceutics committee of Jiangsu Province. Prof. Ping is the editor of JPP and PDA J Pharm Sci & Tech, Acta Pharm Sinica, Chinese J New Drug, etc.. Focusing on the oral absorption of drugs and the formulation design, targeting drug delivery nanosystems, Prof. Ping takes charge of 20 projects from the State，published over 300 papers and 5 books and owned 9 New Drug Certificates of SFDA and 8 SIPO patents. He was honored by special award of the State Council, distinguishing teacher of the state, and excellent graduate supervisor of Jiangsu, the second award of teaching achievements of the State and the second award of Sci &Tech progress of Jiangsu and Hubei Province. Adidas Shoes
页面
Package Plan
- Standard: RMB 3,200
- * BUY 3 GET 1 FREE: For four or more delegates from the same company, the fourth one will get a free entry.
- * Delegate fee includes all seminar sessions, comprehensive documentation, 5-star hotel luncheons, tea breaks and cocktail party.
- * Please note that hotel accommodation is NOT included in the delegate fee.
